Launch Sequence Aphrodisia Capsules recalled for undeclared tadalafil
Launch Sequence Aphrodisia Capsules contain undeclared tadalafil, making them an unapproved drug. The recall involves 500 4-count tins distributed nationwide in the USA and Canada.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall of an unapproved drug containing undeclared tadalafil, a pharmaceutical ingredient that poses potential safety risks. The Class I classification mandates a minimum severity score of 4.
Plain-English summary
Launch Sequence Aphrodisia Capsules, manufactured by Loud Muscle Science, are being recalled due to the presence of undeclared tadalafil. Tadalafil is a pharmaceutical ingredient found in FDA-approved medications used for sexual enhancement, but was not disclosed on the product label.
This recall results from marketing the product without FDA approval. The capsules were sold without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), making them an unapproved drug. The recalled product is identified by lot number 2022104, with an expiration date of April 2025.
The affected product was distributed nationwide in the USA and Canada. Consumers who have purchased Launch Sequence Aphrodisia Capsules should refer to the FDA's drug recall website or contact the FDA for guidance on the product.
The recalled product
- Product
- Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.
- Manufacturer
- Loud Muscle Science
- Category
- Drug — Unapproved Drug
- Hazard
- undeclared-tadalafil
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 2022104
- exp. date 04/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27